On Health Policy Archives

Testimony at FDA Science Board Meeting on Bisphenol A for Use in Food Contact Applications

October 31, 2008. The FDA needs to conduct new studies of a much larger and more representative sample of infant formula containers.

Testimony at FDA Part 15 Hearing Over the Counter Cough and Cold Medications for Pediatric Uses

October 2, 2008. The National Research Center for Women & Families’ position is that cough and cold products for children should not continue to be available OTC because they are generally ineffective and pose unnecessary safety risks to our children.

Testimony to FDA Science Board on Bisphenol A (BPA) in Food Containers

September 16, 2008. BPA is used in a variety of products including reusable water bottles, baby bottles, and plastic tableware. Epoxy resins made with BPA are used to coat the insides of canned foods and beverages.

Letter to U.S. Senators and Reps. Urging Them to Include in the Final Consumer Product Safety Commission Reform Act the Senate Language that Eliminates Phthalates in Children’s Products and Childcare Articles

May 14, 2008. Banning phthalates in toys and children’s products will reduce potentially dangerous exposures that could harm children’s development and increase children’s risk of developing cancer and reproductive problems as adults.

Letter to Dr. Janet Woodcock (FDA), Expressing Concern about the Anti-Infective Drugs Advisory Committee (AIDAC) Meetingts Regarding Clinical Trial Designs for Antibiotic Treatments for Community-Acquired Pneumonia (CAP)

May 12, 2008. The undersigned members of the Patient and Consumer Coalition write to express our concerns about the April 1 and 2 meetings of the Anti-Infective Drugs Advisory Committee (AIDAC) regarding clinical trial designs for antibiotic treatments for community-acquired pneumonia (CAP).